BioAdaptives, Inc. (OTC: BDPT) announced that MyndRenew, the nighttime component of its MyndSystem cognitive health platform, has received TruShield Certified status. The certification confirms compliance with anti-doping standards established by the World Anti-Doping Agency (WADA) and the UFC. Combined with the previously certified MyndMed daytime formula, MyndSystem is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes.
The company stated that the certification strengthens its position in the sports nutrition market by supporting potential adoption among professional athletes while also targeting executives and active seniors. BioAdaptives said the milestone could enhance commercialization opportunities, strategic partnerships and broader market adoption as it expands the MyndSystem platform.
For more details, the full press release is available at https://ibn.fm/JNHRs.
BioAdaptives develops and markets science-based health and wellness products for humans and animals. Its formulations are grounded in published research on nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function. More information is available on the company's website at www.bioadaptives.com.
BioMedWire, a specialized communications platform focusing on the latest developments in Biotechnology, Biomedical Sciences, and Life Sciences, is part of the Dynamic Brand Portfolio @IBN. It provides access to a vast network of wire solutions via InvestorWire, article and editorial syndication to over 5,000 outlets, enhanced press release distribution, social media distribution, and tailored corporate communications solutions. With a seasoned team of contributing journalists and writers, BioMedWire serves private and public companies aiming to reach a wide audience of investors, influencers, consumers, journalists, and the general public.
For more information about BioMedWire, visit https://www.BioMedWire.com. The full terms of use and disclaimers are available at https://www.BioMedWire.com/Disclaimer.
